Abstract
Salivary gland carcinomas are a rare group of tumors with diverse histologies. This has led to a lack of good quality data on various aspects of the disease. As a result, there were limited options for treating them. But, with the advent of targeted therapies, a gamut of options has opened up for the same.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have